Altria Group, Inc. (NYSE:MO) recently reported strong 4Q results with a 32% year over year rise in diluted earnings per share. Excluding the impact of special items, diluted EPS grew 10% in 4Q and 7.8% for FY12. The most encouraging aspect of the earnings announcement was that the company reported a 0.4% cigarette volume growth despite a continuing challenging external environment in which the overall category witnessed a decline of nearly 3%. In terms of its smokeless tobacco business, the company seems to be strongly positioned. The acquisition of UST (although for a hefty price tag) has added some impressive smokeless tobacco products including the Skoal and Copenhagen brands which posted a volume growth of nearly 10% in this quarter.
Going forward, investors may be reluctant to invest in domestic tobacco companies due to declining cigarette consumption trends in the country. However, I don’t think there is any need to be so concerned. Altria Group is an impressive company with leading positions in both the cigarette and smokeless category (~50% market share in cigarette category, ~55% in smokeless tobacco category and ~30% in cigars). The diversification into smokeless products and other markets will keep the company on track for future growth. Other domestic tobacco companies like Reynolds American, Inc. (NYSE:RAI) and Lorillard Inc. (NYSE:LO) have also entered the e-cigarette and smokeless tobacco products, but Altria holds an upper hand due to a strong appeal of its Marlboro brand.
As far as the investment opportunity in these tobacco stocks is concerned, I don’t think it is a good idea to buy Reynolds American at the current levels. The company is trading at a premium to Altria despite having a lower expected growth rate and thus, looks overvalued on a PEG basis (Reynolds American has a PEG ratio of 2.19 as compared to Altria’s 1.91). Moreover, the company has seen a 3.5% drop in revenue over the last three quarters with its top brands including Camel and Pall Mall also taking a strong hit. On the other hand, Lorillard is worth a look at current levels. The company is also slowly increasing its global footprint to take advantage of increasing cigarette consumption in other international markets and the stock looks attractively priced with a PEG ratio of just 1.67.
I acknowledge that Altria Group has experienced an annual revenue decay rate of 14.5% over the last five years, but over the same period the company has posted an annual earnings growth of 7.85%. Thus, one can’t simply write of the company with such margin expanding capabilities. The company has made a significant progress on its cost reduction program by reducing headcount, consolidating certain facilities and improving business processes. Moreover, the management seems confidence to achieve annualized savings of $400 million in 2013 as compared to the previously planned spending.